FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2963860849> ?p ?o ?g. }

• W2963860849 endingPage "e31" @default.
• W2963860849 startingPage "e27" @default.
• W2963860849 abstract "Statins exert pleiotropic anti-inflammatory and immune-modulatory effects, which might translate into antiviral activity. We evaluated whether reported current statin exposure is associated with lower levels of markers of HIV persistence and immune activation/inflammation.We compared levels of markers of HIV viral persistence [cell-associated HIV RNA (CA-RNA), CA-DNA, and single copy assay plasma HIV RNA] and immune activation/inflammation (IL-6, IP-10, neopterin, sCD14, sCD163, and TNF-alpha) between statin users and nonusers among participants of ACTG A5321 who initiated antiretroviral therapy (ART) during chronic infection and maintained virologic suppression (HIV-1 RNA levels ≤50 copies/mL) for ≥3 years.A total of 303 participants were analyzed. Median time on the current statin was 2.9 years (1.2-5.1). There were no differences between statin users and nonusers in levels of CA-DNA (median 650 vs. 540 copies/10 CD4 T cells; P = 0.58), CA-RNA (53 vs. 37 copies/10 CD4 T cells; P = 0.12), or single copy assay (0.4 vs. 0.4 copies/mL; P = 0.45). Similarly, there were no significant differences between statin users and nonusers in markers of inflammation/activation, except for IP-10 (137 vs. 118 pg/mL; P = 0.028). Findings were unchanged after adjustment for factors including pre-ART CD4 and HIV RNA, and years on ART.In this cohort of persons on long-term suppressive ART, current statin use was not associated with lower levels of HIV persistence or immune activation/inflammation. These results do not support a major role for statins in reducing HIV persistence, although an early transient effect cannot be excluded. Prospective, randomized studies are needed to confirm these findings." @default.
• W2963860849 created "2019-07-30" @default.
• W2963860849 creator A5002926065 @default.
• W2963860849 creator A5014123991 @default.
• W2963860849 creator A5014691061 @default.
• W2963860849 creator A5024560316 @default.
• W2963860849 creator A5025707130 @default.
• W2963860849 creator A5025984594 @default.
• W2963860849 creator A5029030800 @default.
• W2963860849 creator A5030394588 @default.
• W2963860849 creator A5038042305 @default.
• W2963860849 creator A5038307269 @default.
• W2963860849 creator A5045529124 @default.
• W2963860849 creator A5045798293 @default.
• W2963860849 creator A5053042121 @default.
• W2963860849 creator A5054159233 @default.
• W2963860849 creator A5056192307 @default.
• W2963860849 creator A5061630637 @default.
• W2963860849 creator A5089200421 @default.
• W2963860849 creator A5090348690 @default.
• W2963860849 date "2019-10-01" @default.
• W2963860849 modified "2023-09-27" @default.
• W2963860849 title "Brief Report: No Evidence for an Association Between Statin Use and Lower Biomarkers of HIV Persistence or Immune Activation/Inflammation During Effective ART" @default.
• W2963860849 cites W1509054451 @default.
• W2963860849 cites W1525331105 @default.
• W2963860849 cites W2011793292 @default.
• W2963860849 cites W2015406420 @default.
• W2963860849 cites W2017871510 @default.
• W2963860849 cites W2022252236 @default.
• W2963860849 cites W2025043471 @default.
• W2963860849 cites W2029938413 @default.
• W2963860849 cites W2063421623 @default.
• W2963860849 cites W2073132242 @default.
• W2963860849 cites W2078438582 @default.
• W2963860849 cites W2124086609 @default.
• W2963860849 cites W2131614631 @default.
• W2963860849 cites W2162654321 @default.
• W2963860849 cites W2168471161 @default.
• W2963860849 cites W2330970697 @default.
• W2963860849 cites W2415904000 @default.
• W2963860849 cites W2461588541 @default.
• W2963860849 cites W2523024742 @default.
• W2963860849 cites W2528418626 @default.
• W2963860849 cites W2592897686 @default.
• W2963860849 cites W2594208926 @default.
• W2963860849 cites W2607139324 @default.
• W2963860849 cites W2740697934 @default.
• W2963860849 cites W2889447954 @default.
• W2963860849 doi "https://doi.org/10.1097/qai.0000000000002124" @default.
• W2963860849 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6799994" @default.
• W2963860849 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31335587" @default.
• W2963860849 hasPublicationYear "2019" @default.
• W2963860849 type Work @default.
• W2963860849 sameAs 2963860849 @default.
• W2963860849 citedByCount "11" @default.
• W2963860849 countsByYear W29638608492020 @default.
• W2963860849 countsByYear W29638608492021 @default.
• W2963860849 countsByYear W29638608492023 @default.
• W2963860849 crossrefType "journal-article" @default.
• W2963860849 hasAuthorship W2963860849A5002926065 @default.
• W2963860849 hasAuthorship W2963860849A5014123991 @default.
• W2963860849 hasAuthorship W2963860849A5014691061 @default.
• W2963860849 hasAuthorship W2963860849A5024560316 @default.
• W2963860849 hasAuthorship W2963860849A5025707130 @default.
• W2963860849 hasAuthorship W2963860849A5025984594 @default.
• W2963860849 hasAuthorship W2963860849A5029030800 @default.
• W2963860849 hasAuthorship W2963860849A5030394588 @default.
• W2963860849 hasAuthorship W2963860849A5038042305 @default.
• W2963860849 hasAuthorship W2963860849A5038307269 @default.
• W2963860849 hasAuthorship W2963860849A5045529124 @default.
• W2963860849 hasAuthorship W2963860849A5045798293 @default.
• W2963860849 hasAuthorship W2963860849A5053042121 @default.
• W2963860849 hasAuthorship W2963860849A5054159233 @default.
• W2963860849 hasAuthorship W2963860849A5056192307 @default.
• W2963860849 hasAuthorship W2963860849A5061630637 @default.
• W2963860849 hasAuthorship W2963860849A5089200421 @default.
• W2963860849 hasAuthorship W2963860849A5090348690 @default.
• W2963860849 hasBestOaLocation W29638608492 @default.
• W2963860849 hasConcept C104317684 @default.
• W2963860849 hasConcept C126322002 @default.
• W2963860849 hasConcept C127413603 @default.
• W2963860849 hasConcept C187320778 @default.
• W2963860849 hasConcept C203014093 @default.
• W2963860849 hasConcept C2776603314 @default.
• W2963860849 hasConcept C2776839432 @default.
• W2963860849 hasConcept C2776914184 @default.
• W2963860849 hasConcept C2781009140 @default.
• W2963860849 hasConcept C54355233 @default.
• W2963860849 hasConcept C67705224 @default.
• W2963860849 hasConcept C71924100 @default.
• W2963860849 hasConcept C86803240 @default.
• W2963860849 hasConcept C8891405 @default.
• W2963860849 hasConceptScore W2963860849C104317684 @default.
• W2963860849 hasConceptScore W2963860849C126322002 @default.
• W2963860849 hasConceptScore W2963860849C127413603 @default.
• W2963860849 hasConceptScore W2963860849C187320778 @default.
• W2963860849 hasConceptScore W2963860849C203014093 @default.
• W2963860849 hasConceptScore W2963860849C2776603314 @default.

• next